🚀Kick off meeting PERSEO looking forward to start working together Instituto de Salud Carlos III (ISCIII) @leadartis UAI_imas12 @CIBERONC CNIO Stop Cancer @jon_zuga Luis Paz-Ares Luis Álvarez-Vallina Irene Ferrer Sánchez #EGFR #4-1BB #Trimerbody

Y muchas más!!!! He aquí todo nuestro equipazo! Nosotras podemos ✊ Vosotras podéis! 💪 #DiaMujerYNinaEnCiencia

Kick off meeting iLung 2.0 💊Terapias personalizadas y 🔬nanotecnología en cáncer de pulmón🫁Complutense CNIO Stop Cancer Luis Paz-Ares Ucero_AC Irene Ferrer Sánchez @m_malumbres Malumbres Lab #javierTamayo CSIC Mariano Barbacid

Kick-off meeting of a new #IRP grant with our friends Paz-Ares's Lab with this help Inserm recognizes many years exchanging ideas, tools and techniques with our lab @IRCM_MTP to fight lung cancer. Many more years to come of this great collaboration!

El #Hospital12deOctubre lidera un ensayo que demuestra reducción en la progresión de un tipo de cáncer de pulmón en un 34%. #somosdel12. #cienciaenel12. UAI_imas12 larazon.es/salud/reducen-… vía La Razón

Today our important study on air pollutants in the promotion of lung cancer has been published in nature led by Will Hill Emilia Lim Clare Weeden Swanton Lab ...Thread below🧵nature.com/articles/s4158…

We're thrilled to share work on tumour evolution in 421 TRACERx lung cancer patients by Alex Frankell Michelle Dietzen Maise Al Bakir Emilia Lim Takahiro Karasaki Sophie Ward RajuVeeriah Emma Colliver Ariana Huebner Abi Bunkum Simone Zaccaria @MariamJHanjani Nicholas McGranahan🧵⬇️ nature.com/articles/s4158…

Delighted to present our paper on the evolutionary characterisation of lung adenocarcinoma (LUAD) morphology in the TRACERx cohort, published Nature Medicine led by Takahiro Karasaki david moore Nicholas McGranahan @MariamJHanjani Swanton Lab nature.com/articles/s4159…

Excited to share our TRACERx nature publication on circulating tumor DNA (#ctDNA, #MRD) detection in resectable lung cancer led by @AbboshChris, @Afrankell, Judit Kisistok, Thomas Harrison, Aaron Garnett, Nicolai Birkbak and Nicholas McGranahan 👇👇👇 Tweetorial🧵 nature.com/articles/s4158…

Simplify manuscript submissions in academic journals! - ¡Firma la petición! chng.it/wQR9vVGr vía Change.org España

Datos que de nuevo reflejan la necesidad de acciones de apoyo a las mujeres investigadoras. Esta gráfica de tijera no cambia!

Second day of #TargetingRAS in @CICancer_com 🧑‍🔬 Check out our posters (61 and 73) to see our latest contributions. What a great opportunity to share knowledge and experiences!

What a great event to acquire new ideas and share knowledge! If you want to know our latest contributions, visit 1280P, 1281P and 1311P. We wait for you! #ESMO2023

El Hospital 12 de Octubre de Madrid recibe el premio Best In Class a Mejor Unidad en Investigación en Oncología Gaceta Médica. Orgullosos de formar parte de este gran equipo! #PremiosBIC2023

Kick off meeting EFFESO Impresive team🏆 #Immunotherapy #CD137 Luis Paz-Ares @leadartis Luis Álvarez-Vallina Agencia Estatal de Investigación CNIO Stop Cancer UAI_imas12 Puerta de Hierro #Proyectoscolaboraciónpúblicoprivada 🧬🧫🔬

🔬🚀Great PhD Viva Santiago G Borrego, PhD Congrats!We will miss you in the lab

🌞We are recruiting🌞 🎯Are you interested in cancer genomics, computational biology, and immune-oncology Just apply🔽

🟢Irene Ferrer and her research journey UAI_imas12 CNIO Stop Cancer Irene Ferrer Sánchez #JornadasInvestigadoresJunior25

So proud to finally share this amazing work, made possible thanks to a fantastic and diverse multidisciplinary team. Huge congrats to everyone involved! Interleukin‐11 promotes lung adenocarcinoma tumourigenesis and immune evasion - Clin Trans Med - onlinelibrary.wiley.com/doi/10.1002/ct…

Investigadores del Instituto i+12 identifican la interleucina-11 (IL-11) como un elemento clave en la progresión del adenocarcinoma de pulmón. | ⁦Irene Ferrer Sánchez⁩ ⁦Luis Paz-Ares⁩ ⁦Asociación Española Contra el Cáncer⁩ ⁦⁩ ⁦Hospital Universitario 12 de Octubre⁩ #imas12 imas12.es/blog/interleuc…